Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hermann Lage

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|April 19, 2012
Enhanced immunoreactivity of TIMP-2 in the stromal compartment of tumor as a marker of favorable prognosis in ovarian cancer patientsAgnieszka Hałoń, Ewa Nowak-Markwitz, Piotr Donizy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapyBeate Rau, Isrid Sturm, Hermann Lage, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 31, 2007
Impact of radiation therapy on the oncolytic adenovirus dl520: implications on the treatment of glioblastomaAlexa Bieler, Klaus Mantwill, Regina Holzmüller, et al.
Oncology Reports|November 4, 2009
Positive correlation between cyclooxygenase-2 and ABC-transporter expression in non-Hodgkin's lymphomasKatarzyna Szczuraszek, Verena Materna, Agnieszka Halon, et al.
Anticancer Research|June 3, 2006
CD24 expression is specific for tamoxifen-resistant ductal breast cancer casesPawel Surowiak, Verena Materna, Piotr Paluchowski, et al.
Neoplasia (New York, N.Y.)|September 28, 2007
The gene polymorphism of the angiotensin I-converting enzyme correlates with tumor size and patient survival in colorectal cancer patientsChristoph Röcken, Konrad Neumann, Stacy Carl-McGrath, et al.
Pathology Oncology Research : POR|January 6, 2011
Estrogen receptor alpha expression in ovarian cancer predicts longer overall survivalAgnieszka Halon, Verena Materna, Malgorzata Drag-Zalesinska, et al.
Anticancer Research|March 8, 2011
Loss of estrogen receptor beta expression correlates with shorter overall survival and lack of clinical response to chemotherapy in ovarian cancer patientsAgnieszka Halon, Ewa Nowak-Markwitz, Adam Maciejczyk, et al.
Histology and Histopathology|February 20, 2008
Decreased expression of p16 in ovarian cancers represents an unfavourable prognostic factorPawel Surowiak, Verena Materna, Adam Maciejczyk, et al.
Cancer Research|July 20, 2006
Inhibition of the multidrug-resistant phenotype by targeting YB-1 with a conditionally oncolytic adenovirus: implications for combinatorial treatment regimen with chemotherapeutic agentsKlaus Mantwill, Nadia Köhler-Vargas, Alexandra Bernshausen, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|April 19, 2012
Enhanced immunoreactivity of TIMP-2 in the stromal compartment of tumor as a marker of favorable prognosis in ovarian cancer patientsAgnieszka Hałoń, Ewa Nowak-Markwitz, Piotr Donizy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapyBeate Rau, Isrid Sturm, Hermann Lage, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 31, 2007
Impact of radiation therapy on the oncolytic adenovirus dl520: implications on the treatment of glioblastomaAlexa Bieler, Klaus Mantwill, Regina Holzmüller, et al.
Oncology Reports|November 4, 2009
Positive correlation between cyclooxygenase-2 and ABC-transporter expression in non-Hodgkin's lymphomasKatarzyna Szczuraszek, Verena Materna, Agnieszka Halon, et al.
Anticancer Research|June 3, 2006
CD24 expression is specific for tamoxifen-resistant ductal breast cancer casesPawel Surowiak, Verena Materna, Piotr Paluchowski, et al.
Neoplasia (New York, N.Y.)|September 28, 2007
The gene polymorphism of the angiotensin I-converting enzyme correlates with tumor size and patient survival in colorectal cancer patientsChristoph Röcken, Konrad Neumann, Stacy Carl-McGrath, et al.
Pathology Oncology Research : POR|January 6, 2011
Estrogen receptor alpha expression in ovarian cancer predicts longer overall survivalAgnieszka Halon, Verena Materna, Malgorzata Drag-Zalesinska, et al.
Anticancer Research|March 8, 2011
Loss of estrogen receptor beta expression correlates with shorter overall survival and lack of clinical response to chemotherapy in ovarian cancer patientsAgnieszka Halon, Ewa Nowak-Markwitz, Adam Maciejczyk, et al.
Histology and Histopathology|February 20, 2008
Decreased expression of p16 in ovarian cancers represents an unfavourable prognostic factorPawel Surowiak, Verena Materna, Adam Maciejczyk, et al.
Cancer Research|July 20, 2006
Inhibition of the multidrug-resistant phenotype by targeting YB-1 with a conditionally oncolytic adenovirus: implications for combinatorial treatment regimen with chemotherapeutic agentsKlaus Mantwill, Nadia Köhler-Vargas, Alexandra Bernshausen, et al.
Pageof 13